Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid for Recovery After Carpal Tunnel Release
NCT02382328Phase 2Completed
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in carpal tunnel syndrome (CTS) comparing alpha lipoic acid with Placebo (2 arms). Primary endpoint: median nerve sensory latency at 120 days. Started Feb 2016; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT02382328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382328.